
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
Biomaterials are crucial to medicine because they help patients recuperate from disease or injury by restoring function.
Biomaterials are used in medical applications to sustain, improve, or replace damaged tissue or a biological function. They can be natural or manufactured.
Heart pacemakers, skin grafts, vascular grafts, and hernia mesh are a few examples of biomaterials. Artificial joints, cochlear implants, contact lenses, and sutures are examples of additional biomaterials.
Metals, ceramics, and polymers are the three categories into which biomaterials are typically divided. A lot of study has looked at combining the advantages of different materials by making composites.
Biomaterials are substances created with the intention of interacting with biological systems in order to treat, improve, or replace biological processes. a few of the most popular biomaterials or biocompatible materials.
Some of the most crucial characteristics of biomaterials that should be carefully examined and assessed prior to implantation are tensile strength, yield strength, elastic modulus, corrosion, creep, and hardness.
The purpose of biomaterials is to replace or repair damaged organs or tissues inside the body. When in contact with human cells, tissue, and organs, biomaterials frequently possess unique qualities that prevent the body from rejecting them.
Blood, bone, proteins, muscle, and other organic components are examples of biological materials, which are created by living things. Contrarily, biomaterials are substances designed expressly for use in biological applications.
The Global Biomaterial medical devices market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
In order to enhance the union between the implant and the bone, Evonik has created a novel osteoconductive polyether ether ketone (PEEK) for the medical technology sector.
The specialty chemicals company is introducing a new line of next-generation products along with the new biomaterial.
The new material's osteoconductive properties, which were made possible by the use of a unique functional additive called biphasic calcium phosphate, enable bone cells to adhere to implants more quickly, positively influencing the process of fusion, or osteointegration, at the implant-to-bone interface. This will hasten bone fusion and recovery as a result.
Customers will be impressed by iC4800, the first biomaterial in Evonik's new Fusion product line, for its exceptional mechanical qualities that are comparable to those of human bone.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024- 2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |